drugset / Trial / NCT03430934

Non-invasive Fluorescent Imaging System for Imaging Mohs Tumor

NCT03430934

Phase 0 Completed 11 enrolled University of Missouri-Columbia
NaSingle-groupOpen-labelDevice feasibility

Summary

The objective of this study is to correlate traditional histological Mohs tissue mapping of a cutaneous tumor with the ICG-mapping procedure. The use of intradermal ICG in a cutaneous tumor during MMS followed by visualization using a fluorescent imaging system could allow surgeons to directly visualize, and roughly map the extent of a primary skin cancer and plan the Mohs procedure (i.e. the initial excision size and subsequent layer widths) accordingly.

Timeline

Start
2018-07-01
Primary completion
2019-08-01
Completion
2019-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Indocyanine Green Diagnostic / imaging agent

Indications